Hydroxychloroquine Attenuates Myocardial Ischemic and Post-Ischemic Reperfusion Injury by Inhibiting the Toll-Like Receptor 9 – Type I Interferon Pathway. (2022). Cardiology and Cardiovascular Medicine, 6(4), 416-423. https://fortunejournals.org/ojs/index.php/ccm/article/view/16285